Filing Details
- Accession Number:
- 0001104659-10-060752
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-01 18:05:29
- Reporting Period:
- 2010-11-30
- Filing Date:
- 2010-12-01
- Accepted Time:
- 2010-12-01 18:05:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1411158 | Anacor Pharmaceuticals Inc | ANAC | Pharmaceutical Preparations (2834) | 251854385 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 935463 | H Paul Klingenstein | 428 University Ave C/O Accel Partners Palo Alto CA 94301 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-11-30 | 12,966 | $0.00 | 12,966 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2010-11-30 | 13,478 | $0.00 | 26,444 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2010-11-30 | 23,688 | $0.00 | 50,132 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2010-11-30 | 3,821 | $0.00 | 53,953 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2010-11-30 | 4,048 | $0.00 | 58,001 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2010-11-30 | 324,975 | $0.00 | 324,975 | No | 4 | C | Indirect | See Footnote |
| Common Stock | Acquisiton | 2010-11-30 | 337,831 | $0.00 | 662,806 | No | 4 | C | Indirect | See Footnote |
| Common Stock | Acquisiton | 2010-11-30 | 593,697 | $0.00 | 1,256,503 | No | 4 | C | Indirect | See Footnote |
| Common Stock | Acquisiton | 2010-11-30 | 95,788 | $0.00 | 1,352,291 | No | 4 | C | Indirect | See Footnote |
| Common Stock | Acquisiton | 2010-11-30 | 99,645 | $0.00 | 1,451,936 | No | 4 | C | Indirect | See Footnote |
| Common Stock | Acquisiton | 2010-11-30 | 300,000 | $5.00 | 1,751,936 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Indirect | See Footnote |
| No | 4 | C | Indirect | See Footnote |
| No | 4 | C | Indirect | See Footnote |
| No | 4 | C | Indirect | See Footnote |
| No | 4 | C | Indirect | See Footnote |
| No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A-1 Preferred Stock | Disposition | 2010-11-30 | 12,966 | $0.00 | 12,966 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2010-11-30 | 10,240 | $0.00 | 13,478 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2010-11-30 | 23,688 | $0.00 | 23,688 | $0.00 |
| Common Stock | Series D Preferred Stock | Disposition | 2010-11-30 | 3,821 | $0.00 | 3,821 | $0.00 |
| Common Stock | Series E Preferred Stock | Disposition | 2010-11-30 | 4,048 | $0.00 | 4,048 | $0.00 |
| Common Stock | Series A-1 Preferred Stock | Disposition | 2010-11-30 | 324,975 | $0.00 | 324,975 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2010-11-30 | 256,651 | $0.00 | 337,831 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2010-11-30 | 593,697 | $0.00 | 593,697 | $0.00 |
| Common Stock | Series D Preferred Stock | Disposition | 2010-11-30 | 95,788 | $0.00 | 95,788 | $0.00 |
| Common Stock | Series E Preferred Stock | Disposition | 2010-11-30 | 99,645 | $0.00 | 99,645 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- The Series A-1 Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock converted into Common Stock on a 1-for-1 basis and had no expiration date.
- The Series B Preferred Stock converted into Common Stock on the basis of 1.316 shares of Common Stock for one share of Series B Preferred Stock and had no expiration date.
- Consists of 7,203 shares held by Aberdare Ventures II (Bermuda), L.P. and 317,772 shares held be Aberdare Ventures II, L.P. The reporting person is a managing director of Aberdare GP II, LLC, the general partner of each of Aberdare Ventures II (Bermuda), L.P. and Aberdare Ventures II, L.P. The reporting person disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that such filer is the beneficial owner of such securities, except to the extent of his pecuniary interest therein.
- Consists of 7,488 shares held by Aberdare Ventures II (Bermuda), L.P. and 330,343 shares held be Aberdare Ventures II, L.P. The reporting person is a managing director of Aberdare GP II, LLC, the general partner of each of Aberdare Ventures II (Bermuda), L.P. and Aberdare Ventures II, L.P. The reporting person disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that such filer is the beneficial owner of such securities, except to the extent of his pecuniary interest therein.
- Consists of 13,160 shares held by Aberdare Ventures II (Bermuda), L.P. and 580,537 shares held be Aberdare Ventures II, L.P. The reporting person is a managing director of Aberdare GP II, LLC, the general partner of each of Aberdare Ventures II (Bermuda), L.P. and Aberdare Ventures II, L.P. The reporting person disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that such filer is the beneficial owner of such securities, except to the extent of his pecuniary interest therein.
- Consists of 2,123 shares held by Aberdare Ventures II (Bermuda), L.P. and 93,665 shares held be Aberdare Ventures II, L.P. The reporting person is a managing director of Aberdare GP II, LLC, the general partner of each of Aberdare Ventures II (Bermuda), L.P. and Aberdare Ventures II, L.P. The reporting person disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that such filer is the beneficial owner of such securities, except to the extent of his pecuniary interest therein.
- Consists of 99,645 shares held by Aberdare II Annex Fund, L.P. The reporting person is a managing director of Aberdare GP II, LLC, the general partner of Aberdare II Annex Fund, L.P. The reporting person disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that such filer is the beneficial owner of such securities, except to the extent of his pecuniary interest therein.
- Consists of 300,000 shares held by Aberdare II Annex Fund, L.P. The reporting person is a managing director of Aberdare GP II, LLC, the general partner of Aberdare II Annex Fund, L.P. The reporting person disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that such filer is the beneficial owner of such securities, except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
